Page 2 - Robert Berman News Today

$46.4 million cash and investments on hand sufficient to fund current operations, including multiple value driving milestones, through the end of 2025Topline efficacy data for VenoValve® U.S. pivotal trial to be presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024Continued progress towar...

EnVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial ...

Insiders were net buyers of Rekor Systems, Inc.'s ( NASDAQ:REKR ) stock during the past year. That is, insiders bought...

EnVVeno Medical Posts Company Highlights and Materials from 2023 VEITH ...

Operator: Good morning, ladies and gentlemen. And welcome to today’s Rekor Systems, Inc. Conference Call. My name is John, and I’ll be your coordinator for today.

EnVVeno Medical Reports Third Quarter 2023 Financial Results and Provides ...

EnVVeno Medical to Participate at the Virtual Investor Ask the CEO ...

IRVINE - enVVeno Medical Corporation , a company setting new standards of care for the treatment of venous disease, today announced a plan to expedite the development of enVVe, its transcatheter...

EnVVeno Medical Reports Second Quarter 2023 Financial Results and Provides ...

EnVVeno Medical Reports First Quarter 2023 Financial Results and Provides ...